However, the association of neonatal inflammatory proteins and neurotrophic proteins with ADHD outcomes is a novel finding, and further work to evaluate methods of modifying these neonatal outcomes or moderating their effect on ADHD is warranted. The gene discussed is PROS1; the disease is attention deficit-hyperactivity disorder.